ReviewFEMS yeast research2026
Life beyond 6000 genes: from sequence to synthesis in a post-genomics era.
Review in FEMS yeast research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The publication of the Saccharomyces cerevisiae genome sequence thirty years ago marked a defining shift in modern biology, establishing yeast as the first fully sequenced eukaryotic model cell. Access to a complete reference genome has catalyzed a renaissance in experimental biology, providing the foundation for advances in functional genomics, systems biology, synthetic biology, and biotechnology. This article celebrates the achievements of the yeast sequencing project and highlights how genomics has evolved from a descriptive resource into a central enabling infrastructure for engineering biology, leading to a post-genomic era defined by genome-scale design. We chart the progression from decoding the genome to the omics revolution, highlighting both recent discoveries and persistent enigmas surrounding the 'dark matter' of the yeast genome. We then describe how access to a well-annotated reference genome has culminated in a new era of synthetic genomics exemplified by the Sc2.0 project. Finally, we explore how emerging trends in artificial intelligence and bioelectronics may shape the next thirty years of yeast genomics and engineering biology. This integration of past achievements and future trajectories reinforces the enduring role of S. cerevisiae as a primary eukaryotic model for biological discovery and biotechnological innovation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.